Contents

Current Drug Targets - Infectious Disorders, Volume 2 - Number 3

Antiretroviral Therapy Regimens for Neuro-AIDS

, 2(3): 187 - 192

G. Arendt and H. J. von Giesen


DOI: 10.2174/1568005023342425




Pandemic of Atopic Diseases - A Lack of Microbial Exposure in Early Infancy?

, 2(3): 193 - 199

M. Kalliomaki and E. Isolauri


DOI: 10.2174/1568005023342452




Strategic Targeting of Essential Host-pathogen Interactions in Chlamydial Disease

, 2(3): 201 - 216

B. K. Coombes, D. L. Johnson and J. B. Mahony


DOI: 10.2174/1568005023342362




Structure-Based Inhibitor Design Targeting HIV-1 Integrase

, 2(3): 217 - 234

I-Jen Chen, Nouri Neamati, Alexander D. MacKerell and Jr.


DOI: 10.2174/1568005023342380




Histidine Kinase-mediated Signal Transduction Systems of Pathogenic Microorganisms as Targets for Therapeutic Intervention

, 2(3): 235 - 246

K. Stephenson and J. A. Hoch


DOI: 10.2174/1568005023342443




The Role of the Cytoskeleton in the Life Cycle of Viruses and Intracellular Bacteria: Tracks, Motors, and Polymerization Machines

, 2(3): 247 - 264

E. L. Bearer and P. Satpute-Krishnan


DOI: 10.2174/1568005023342407




CCR5 Chemokine Receptors: Gatekeepers of HIV-1 Infection

, 2(3): 265 - 278

Wieslaw M. Kazmierski, Larry Boone, Wendell Lawrence, Chris Watson and Terry Kenakin


DOI: 10.2174/1568005023342489




Webmaster Contact: info@benthamscience.org
Copyright © 2018 Bentham Science